Structural insights into the assembly and activation of IL-1β 2 with its receptors

Nature Immunology

Volumn 11, Issue 10, 2010, Pages 905-911

  Wang, Dongli ^a   Zhang, Senyan ^a   Li, Liang ^a   Liu, Xi ^a   Mei, Kunrong ^a   Wang, Xinquan ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA; PROTEIN BINDING;

ARTICLE; BINDING SITE; CRYSTAL STRUCTURE; HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; STRUCTURE ANALYSIS; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLOGRAPHY; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CRYSTALLOGRAPHY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN-1BETA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-1 TYPE II; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 77956950823     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1925     Document Type: Article

References (55)

1. Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147 (1996).
2. Barksby, H.E., Lea, S.R., Preshaw, P.M. & Taylor, J.J. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol. 149, 217-225 (2007).
3. Dinarello, C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27, 519-550 (2009).
4. Sims, J.E. & Smith, D.E. The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89-102 (2010).
5. Sims, J.E. et al. A new nomenclature for IL-1-family genes. Trends Immunol. 22, 536-537 (2001).
6. Dinarello, C.A. IL-1: discoveries, controversies and future directions. Eur. J. Immunol. 40, 599-606 (2010).
7. Auron, P.E. et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc. Natl. Acad. Sci. USA 81, 7907-7911 (1984).
8. Lomedico, P.T. et al. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312, 458-462 (1984).
9. March, C.J. et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315, 641-647 (1985).
10. Dinarello, C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20, S1-S13 (2002).
11. Braddock, M. & Quinn, A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3, 330-339 (2004).
12. Dinarello, C.A. The many worlds of reducing interleukin-1. Arthritis Rheum. 52, 1960-1967 (2005).
13. Goldbach-Mansky, R. Blocking interleukin-1 in rheumatic diseases. Ann. NY Acad. Sci. 1182, 111-123 (2009).
14. Sims, J.E. et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241, 585-589 (1988).
15. Greenfeder, S.A. et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270, 13757-13765 (1995).
16. Korherr, C., Hofmeister, R., Wesche, H. & Falk, W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262-267 (1997).
17. Cullinan, E.B. et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 161, 5614-5620 (1998).
18. Dunne, A. & ONeill, L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 171, re3 (2003).
19. McMahan, C.J. et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 2821-2832 (1991).
20. Colotta, F. et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261, 472-475 (1993).
21. Colotta, F., Dower, S.K., Sims, J.E. & Mantovani, A. The type II decoy receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15, 562-566 (1994).
22. Lang, D. et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161, 6871-6877 (1998).
23. Malinowsky, D., Lundkvist, J., Laye, S. & Bartfai, T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429, 299-302 (1998).
24. Boraschi, D. & Tagliabue, A. The interleukin-1 receptor family. Vitam. Horm. 74, 229-254 (2006).
25. Smith, D.E. et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18, 87-96 (2003).
26. Vigers, G.P., Anderson, L.J., Caffes, P. & Brandhuber, B.J. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β. Nature 386, 190-194 (1997).
27. Schreuder, H. et al. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386, 194-200 (1997).
28. Boraschi, D., Bossu, P., Macchia, G., Ruggiero, P. & Tagliabue, A. Structure-function relationship in the IL-1 family. Front. Biosci. 1, d270-d308 (1996).
29. Vigers, G.P., Dripps, D.J., Edwards, C.K. III & Brandhuber, B.J. X-ray crystal structure of a small antagonist peptide bound to interleukin-1 receptor type 1. J. Biol. Chem. 275, 36927-36933 (2000).
30. Casadio, R. et al. Model of interaction of the IL-1 receptor accessory protein IL-1RAcP with the IL-1β/IL-1R(I) complex. FEBS Lett. 499, 65-68 (2001).
31. Lingel, A. et al. Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors-insight into heterotrimeric IL-1 signaling complexes. Structure 17, 1398-1410 (2009).
32. Yoon, D.Y. & Dinarello, C.A. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1β activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein. J. Immunol. 160, 3170-3179 (1998).
33. Simoncsits, A. et al. Deletion mutants of human interleukin 1β with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Cytokine 6, 206-214 (1994).
34. Ju, G. et al. Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis. Proc. Natl. Acad. Sci. USA 88, 2658-2662 (1991).
35. DEttorre, C., De Chiara, G., Casadei, R., Boraschi, D. & Tagliabue, A. Functional epitope mapping of human interleukin-1β by surface plasmon resonance. Eur. Cytokine Netw. 8, 161-171 (1997).
36. Greenfeder, S.A. et al. Insertion of a structural domain of interleukin (IL)-1β confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity. J. Biol. Chem. 270, 22460-22466 (1995).
37. Kawashima, H. et al. Structure-activity relationships in human interleukin-1β: identification of key residues for expression of biological activities. Protein Eng. 5, 171-176 (1992).
38. Torigoe, K. et al. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272, 25737-25742 (1997).
39. Born, T.L., Thomassen, E., Bird, T.A. & Sims, J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273, 29445-29450 (1998).
40. Kato, Z. et al. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 10, 966-971 (2003).
41. Kim, S.H. et al. Identification of amino acid residues critical for biological activity in human interleukin-18. J. Biol. Chem. 277, 10998-11003 (2002).
42. Kim, S.H. et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc. Natl. Acad. Sci. USA 97, 1190-1195 (2000).
43. Krumm, B., Meng, X., Li, Y., Xiang, Y. & Deng, J. Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein. Proc. Natl. Acad. Sci. USA 105, 20711-20715 (2008).
44. Argiriadi, M.A., Xiang, T., Wu, C., Ghayur, T. & Borhani, D.W. Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18. J. Biol. Chem. 284, 24478-24489 (2009).
45. Wang, X., Lupardus, P., Laporte, S.L. & Garcia, K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27, 29-60 (2009).
46. Leslie, A. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 26 (1992).
47. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994).
48. Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 8060-8065 (2006).
49. McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658-674 (2007).
50. Priestle, J.P., Schar, H.P. & Grutter, M.G. Crystallographic refinement of interleukin 1β at 2.0 resolution. Proc. Natl. Acad. Sci. USA 86, 9667-9671 (1989).
51. Schneider, T.R. & Sheldrick, G.M. Substructure solution with SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58, 1772-1779 (2002).
52. Adams, P.D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948-1954 (2002).
53. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004).
54. Brunger, A.T. Version 1.2 of the Crystallography and NMR system. Nat. Protocols 2, 2728-2733 (2007).
55. DeLano, W.L. Pymol Molecular Graphics System (DeLano Scientific, San Carlos, California, 2002).